{
    "organizations": [],
    "uuid": "5fa5b6a74eba8579dc5e7ee8c25f5d075864b8a7",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-guangzhou-baiyunshan-pharmaceutica/brief-guangzhou-baiyunshan-pharmaceutical-holdings-co-says-qtrly-net-profit-attributable-rmb905-2-mln-idUSFWN1S31DO",
    "ord_in_thread": 0,
    "title": "Guangzhou Baiyunshan Pharmaceutical Holdings Co Says Qtrly Net Profit Attributable RMB905.2 Mln",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 26 (Reuters) - Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd:\n* QTRLY INCOME FROM OPERATIONS RMB 6.91 BILLION VERSUS RMB5.29 BILLION\n* QTRLY NET PROFIT ATTRIBUTABLE TO SHAREHOLDERS RMB905.2 MILLION VERSUS RMB484.7 MILLION Source text for Eikon:\n ",
    "published": "2018-04-26T22:37:00.000+03:00",
    "crawled": "2018-04-27T16:53:09.012+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "guangzhou",
        "baiyunshan",
        "pharmaceutical",
        "holding",
        "co",
        "ltd",
        "qtrly",
        "income",
        "operation",
        "rmb",
        "billion",
        "versus",
        "billion",
        "qtrly",
        "net",
        "profit",
        "attributable",
        "shareholder",
        "million",
        "versus",
        "million",
        "source",
        "text",
        "eikon"
    ]
}